ENTYVIO®
ENTYVIO® (vedolizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells that may cause inflammation. Specifically, it is an integrin receptor antagonist used in adults for the treatment of moderate to severely active Ulcerative Colitis (UC) and moderately to severely active Crohn’s disease.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
